the results of a clinical trial of sultamicillin , a novel mutual pro-drug combination of ampicillin and the beta-lactamase inhibitor sulbactam , in ampicillin-resistant urinary tract infections are reported .
C0002680
ampicillin
C0042029
urinary tract infections